遠東宏信(03360.HK):因轉換而註銷部分債券
格隆匯6月13日丨遠東宏信(03360.HK)發佈公告,自2025年6月7日至本公告日期,本金總額合共2090.5萬美元的債券(佔債券初始本金總額約6.97%)已於2025年6月13日根據條件按當前換股價每股股份5.19港元轉換並註銷,導致合共3121.773萬股股份(佔擔保人於2025年5月31日已發行股本總額約0.72%)已發行及入賬爲繳足股份。
於本公告日期,發行在外的債券本金總額爲約2.45億美元(“發行在外的債券”),佔債券初始本金總額約81.70%。假設按當前換股價每股股份5.19港元(可予調整)悉數轉換,則於2025年5月31日有關轉換所產生的股份將佔擔保人已發行股本總額約8.42%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.